NYSE:LCI - Lannett Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$13.50 -0.25 (-1.82 %)
(As of 08/19/2018 03:26 AM ET)
Previous Close$13.50
Today's Range$13.1750 - $13.80
52-Week Range$11.90 - $30.35
Volume688,954 shs
Average Volume679,086 shs
Market Capitalization$515.09 million
P/E Ratio4.72
Dividend YieldN/A
Lannett logoLannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout. In addition, the company manufactures active pharmaceutical ingredients; and markets its products under the Diamox, Lipitor, Lioresal, Fioricet, Fiorinal, Lanoxin, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Imitrex, Brethine, Tussionex, and Actigall brands. Further, it sells pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Pharmaceutical preparations


Debt-to-Equity Ratio1.29
Current Ratio2.56
Quick Ratio1.91


Trailing P/E Ratio4.72
Forward P/E Ratio4.33
P/E GrowthN/A

Sales & Book Value

Annual Sales$633.34 million
Price / Sales0.81
Cash Flow$4.3689 per share
Price / Cash3.09
Book Value$15.07 per share
Price / Book0.90


EPS (Most Recent Fiscal Year)$2.86
Net Income$-580,000.00
Net Margins7.01%
Return on Equity18.64%
Return on Assets6.73%


Outstanding Shares38,010,000
Market Cap$515.09 million

Lannett (NYSE:LCI) Frequently Asked Questions

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) announced its quarterly earnings results on Monday, May, 7th. The company reported $0.80 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.76 by $0.04. The firm had revenue of $174.39 million for the quarter, compared to analyst estimates of $176.51 million. Lannett had a net margin of 7.01% and a return on equity of 18.64%. The business's revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.77 earnings per share. View Lannett's Earnings History.

When is Lannett's next earnings date?

Lannett is scheduled to release their next quarterly earnings announcement on Wednesday, August, 22nd 2018. View Earnings Estimates for Lannett.

What price target have analysts set for LCI?

4 brokerages have issued 12 month price targets for Lannett's shares. Their predictions range from $21.00 to $25.00. On average, they expect Lannett's share price to reach $22.3333 in the next twelve months. This suggests a possible upside of 65.4% from the stock's current price. View Analyst Price Targets for Lannett.

What is the consensus analysts' recommendation for Lannett?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Lannett.

Who are some of Lannett's key competitors?

Who are Lannett's key executives?

Lannett's management team includes the folowing people:
  • Mr. Martin P. Galvan CPA, VP of Fin., CFO & Treasurer (Age 66)
  • Mr. Robert Ehlinger, VP of Logistics & Chief Information Officer (Age 61)
  • Mr. Kevin R. Smith, Sr. VP of Sales & Marketing (Age 58)
  • Mr. John M. Abt, VP of Quality (Age 53)
  • Mr. Arthur P. Bedrosian, Director (Age 72)

Has Lannett been receiving favorable news coverage?

News coverage about LCI stock has been trending positive on Sunday, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Lannett earned a media and rumor sentiment score of 0.25 on Accern's scale. They also gave press coverage about the company an impact score of 46.56 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for Lannett.

Who are Lannett's major shareholders?

Lannett's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Telemus Capital LLC (21.34%), BlackRock Inc. (11.54%), LSV Asset Management (5.52%), Frontier Capital Management Co. LLC (2.21%), Dimensional Fund Advisors LP (2.16%) and Heartland Advisors Inc. (2.13%). Company insiders that own Lannett stock include Arthur P Bedrosian, David Farber, G Michael Landis, James M Maher, Kevin Smith, Patrick G Lepore and Timothy C Crew. View Institutional Ownership Trends for Lannett.

Which major investors are selling Lannett stock?

LCI stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Bank of America Corp DE, Bowling Portfolio Management LLC, KBC Group NV, State Board of Administration of Florida Retirement System, Raymond James & Associates, Globeflex Capital L P and Schwab Charles Investment Management Inc.. Company insiders that have sold Lannett company stock in the last year include Arthur P Bedrosian, David Farber and Kevin Smith. View Insider Buying and Selling for Lannett.

Which major investors are buying Lannett stock?

LCI stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Heartland Advisors Inc., Connor Clark & Lunn Investment Management Ltd., Alambic Investment Management L.P., LSV Asset Management, Quantitative Systematic Strategies LLC, Eqis Capital Management Inc. and Staley Capital Advisers Inc.. Company insiders that have bought Lannett stock in the last two years include Arthur P Bedrosian, Patrick G Lepore and Timothy C Crew. View Insider Buying and Selling for Lannett.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $13.50.

How big of a company is Lannett?

Lannett has a market capitalization of $515.09 million and generates $633.34 million in revenue each year. The company earns $-580,000.00 in net income (profit) each year or $2.86 on an earnings per share basis. Lannett employs 1,126 workers across the globe.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.

MarketBeat Community Rating for Lannett (NYSE LCI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  373 (Vote Outperform)
Underperform Votes:  286 (Vote Underperform)
Total Votes:  659
MarketBeat's community ratings are surveys of what our community members think about Lannett and other stocks. Vote "Outperform" if you believe LCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.